ArticleBriefings in bioinformatics2026
scGACL: a generative adversarial network with multi-scale contrastive learning for accurate single-cell RNA sequencing imputation.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Single-cell RNA sequencing is a powerful technology for investigating cell-to-cell heterogeneity, yet its application is often hindered by dropout events, making accurate imputation essential for downstream analyses. Existing imputation methods, however, frequently suffer from the over-smoothing problem, which results in the loss of cell-to-cell heterogeneity in the imputed outcomes and affects downstream analyses. To overcome this limitation, we propose scGACL, a generative adversarial network (GAN) integrated with multi-scale contrastive learning. The GAN architecture facilitates the distribution of the imputed data to approximate that of the real data. To fundamentally address over-smoothing, the model incorporates a multi-scale contrastive learning mechanism: cell-level contrastive learning preserves fine-grained cell-to-cell heterogeneity, while cell-type-level contrastive learning maintains macroscopic biological variation across different cellular groups. These mechanisms function synergistically to ensure accurate imputation and effectively address the over-smoothing challenge. Comprehensive evaluations across diverse simulated and real-world datasets confirm that scGACL consistently outperforms existing methods in accurately recovering gene expression and improving downstream analyses such as cell clustering, gene differential expression analysis, and cell trajectory inference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.